Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"
Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Dasatinib","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=dasatinib","facts":[{"label":"Active ingredient \/ generic name","value":"dasatinib"},{"label":"ATC code","value":"L01EA02"},{"label":"Administration route","value":"Oral"}]},{"title":"Norodol 10 mg\/ml Damla (Turkish record)","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=norodol-10-mg-ml-damla","facts":[{"label":"Active ingredient \/ generic name","value":"Haloperidol"},{"label":"ATC code","value":"N05AD01"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"DailyMed SPRYCEL SPL v50; effective 2026-10-16; checked 2026-11-04; 5.6"}],"sources":[{"label":"SPRYCEL U.S. prescribing information (DailyMed)","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=4764f37b-c9e6-4ede-bcc2-8a03b7c521df"},{"label":"Tasigna English product information (EMA)","url":"https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/tasigna-epar-product-information_en.pdf"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:35252","available":true}}